Hepatitis B vaccine FSS-BIG4-DOD
Ended Awarded Last action
- Contract number
- W912L613F0007
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Oklahoma National Guard
Army National Guard, Department of Defense
- Obligated
- $3,895
Award facts
- Contract value 100% obligated
- $3,895.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Air National Guard Air Force, Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Tulsa, OK 74115, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract W912L613F0007?
W912L613F0007 was awarded to Glaxosmithkline, LLC by Oklahoma National Guard (Army National Guard) on February 12, 2013.
How much is contract W912L613F0007 worth?
The government has obligated $3,895 on W912L613F0007.
Which agency awarded contract W912L613F0007?
Oklahoma National Guard (Army National Guard) awarded W912L613F0007, with funding from Air National Guard (Air Force).
Is contract W912L613F0007 an order under another contract?
Yes. W912L613F0007 is a delivery order under V797P5799X, a federal supply schedule.
Was contract W912L613F0007 competed?
The extent of competition for W912L613F0007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award